• Explore /
  • Poster
  • / Attitudes toward prevention options in Lynch syndrome (LS): Comparing frameshift peptide vaccination (FSPVAX), colonoscopy (COLO), and aspirin (ASA) chemoprevention.

Attitudes toward prevention options in Lynch syndrome (LS): Comparing frameshift peptide vaccination (FSPVAX), colonoscopy (COLO), and aspirin (ASA) chemoprevention.

Abstract Poster

Authors

Michael Hall

Michael J. Hall

Fox Chase Cancer Center, Philadelphia, PA;

Michael J. Hall , Emma D Riggs , Yana Chertock , Mary Beryl Daly

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Prevention, Screening, and Hereditary Cancers

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 526)

DOI

10.1200/JCO.2023.41.4_suppl.526

Abstract #

526

Poster Bd #

B16

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Perceptions of cancer prevention options for Lynch syndrome (LS) in a multi-national convenience sample.

Perceptions of cancer prevention options for Lynch syndrome (LS) in a multi-national convenience sample.

First Author: Michael J. Hall

First Author: Matthias Kloor

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Prevalence and predictors of aspirin/NSAID use among patients with Lynch syndrome (LS).

Prevalence and predictors of aspirin/NSAID use among patients with Lynch syndrome (LS).

First Author: Sachi Singhal

First Author: Eric Baudin